Insufficient evidence to suggest less stringent therapy in hemophilia B?

Suppr

超能文献

作者信息

den Uijl Ingrid E M, Roosendaal Goris, Fischer Kathelijn

出版信息

Blood. 2009 Nov 26;114(23):4907; author reply 4907-8. doi: 10.1182/blood-2009-08-241240.

DOI:10.1182/blood-2009-08-241240

PMID:19965698

Abstract

摘要

相似文献

Insufficient evidence to suggest less stringent therapy in hemophilia B?

Blood. 2009 Nov 26;114(23):4907; author reply 4907-8. doi: 10.1182/blood-2009-08-241240.

Total knee arthroplasty in hemophilic arthropathy: efficiency of clotting factor usage in multijoint procedures.血友病性关节病的全膝关节置换术：多关节手术中凝血因子的使用效率

J Thromb Haemost. 2009 Oct;7(10):1741-3. doi: 10.1111/j.1538-7836.2009.03569.x. Epub 2009 Aug 11.

[Status of joint and intracranial bleeding of moderate and severe hemophilia in children under on-demand therapy].[按需治疗下儿童中重度血友病关节及颅内出血状况]

Zhonghua Er Ke Za Zhi. 2012 Aug;50(8):636-8.

Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome.重度血友病预防性治疗的中断：发生率及其对预后的影响。

Haemophilia. 2001 Nov;7(6):544-50. doi: 10.1046/j.1365-2516.2001.00560.x.

Prophylaxis in congenital coagulation disorders: past, present and future.先天性凝血障碍的预防：过去、现在与未来

Blood Transfus. 2008 Sep;6 Suppl 2(Suppl 2):s1-3. doi: 10.2450/2008.0029-08.

Pharmacoeconomic impact of obesity in severe haemophilia children on clotting factor prophylaxis in a single institution.单一机构中肥胖对重度血友病儿童凝血因子预防治疗的药物经济学影响

Haemophilia. 2011 Jul;17(4):717-8. doi: 10.1111/j.1365-2516.2010.02462.x. Epub 2011 Feb 16.

FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations.FEIBA 预防治疗在血友病患者中的应用：临床更新与治疗推荐。

Haemophilia. 2010 Jan;16(1):80-9. doi: 10.1111/j.1365-2516.2009.02104.x. Epub 2009 Sep 23.

The overall effectiveness of prophylaxis in severe haemophilia.严重血友病预防治疗的总体疗效。

Haemophilia. 2003 May;9(3):272-8. doi: 10.1046/j.1365-2516.2003.00757.x.

Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy: The Malmö experience.在重度血友病患者的出生队列中，手术和生存情况存在差异，且接受替代治疗的机会也存在差异：马尔默的经验。

Haemophilia. 2017 Sep;23(5):e403-e408. doi: 10.1111/hae.13302. Epub 2017 Jul 31.

On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome.挪威和瑞典重度血友病按需治疗与预防性治疗：治疗特征和结果的差异

Haemophilia. 2003 Sep;9(5):555-66. doi: 10.1046/j.1365-2516.2003.00817.x.

引用本文的文献

Health and treatment outcomes of patients with hemophilia in the Netherlands, 1972-2019.荷兰血友病患者的健康和治疗结果，1972-2019 年。

J Thromb Haemost. 2021 Oct;19(10):2394-2406. doi: 10.1111/jth.15424. Epub 2021 Jul 7.

Differences in Major Bleeding Events Between Patients With Severe Hemophilia A and Hemophilia B: A Nationwide, Population-Based Cohort Study.重型 A 型血友病和 B 型血友病患者主要出血事件的差异：一项全国范围内的基于人群的队列研究。

Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619888023. doi: 10.1177/1076029619888023.

Hemophilia A and B: molecular and clinical similarities and differences.甲型和乙型血友病：分子层面与临床的异同

Haematologica. 2019 Sep;104(9):1702-1709. doi: 10.3324/haematol.2019.221093. Epub 2019 Aug 8.

Comparison of Total Joint Replacement Rate Between Patients With Hemophilia A and Patients With Hemophilia B: A Population-Based and Retrospective Cohort Study.血友病 A 与血友病 B 患者人工关节置换率的比较：基于人群的回顾性队列研究。

Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):163S-170S. doi: 10.1177/1076029618794294. Epub 2018 Sep 13.

The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B.非重度血友病 A 与 B 患者关节出血和关节镜检查的频率。

Blood Adv. 2018 Aug 28;2(16):2136-2144. doi: 10.1182/bloodadvances.2018020552.

Global hemostatic assay of different target procoagulant activities of factor VIII and factor IX.针对凝血因子VIII和凝血因子IX不同靶促凝活性的全球止血检测。

Blood Res. 2018 Mar;53(1):41-48. doi: 10.5045/br.2018.53.1.41. Epub 2018 Mar 27.

Prophylaxis use among males with haemophilia B in the United States.美国乙型血友病男性的预防治疗使用情况。

Haemophilia. 2017 Nov;23(6):910-917. doi: 10.1111/hae.13317. Epub 2017 Aug 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验